BioCellChallenge is Biotechnology company, discovering and developing biological molecule delivery sytems (Antibody, Proteins, Peptides). Its latest patented technology for antibody intracellular delivery allow BioCellchallenge to develop collaborative partnerships with pharmaceutical companies and service companies.

Technology for antibody intracellular delivery

Latest Presse Release

Toulon, France, November 30, 2015

BioCellChallenge obtains unprecedented in-vivo results using intracellular delivery technology for therapeutic antibodies

For the first time, in-vivo tests have shown that an anti-Ras antibody combined with ImmunoCellin technology slows tumor growth in all cases and leads to full recovery in one-third of cases

The company now plans to test its approach with antibody-drug conjugates


BioCellChallenge

BioCellChallenge SAS
Parc d'Activités de Signes
Avenue de Paris
BP90778
83030 Toulon cedex 9 (France)

Latest News

The activity "reagent" for DNA and siRNA was sold to the French company Eurobio

For reagent orders and Opticcine, please contact

 

  • EUROBIO
  • 7 avenue de Scandinavie - 91953 COURTABOEUF Cedex B
  • Tel : +33 1.69.07.94.77
  • Fax : +33 1.69.07.95.34
  • Site : www.eurobio.fr
  • Mail : This email address is being protected from spambots. You need JavaScript enabled to view it.


 
French Riviera

 

From delivery to therapy

BiocellChallenge